Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.

Overview of attention for article published in NEJM Evidence, August 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog
twitter: 13 X users

bluesky: 3 Bluesky users

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 3 Bluesky posts from 3 Bluesky users, with an upper bound of 7,110 followers.

RP @hswapnil.bsky.social: Are you using HIF-PHIs? (I would love to try in predialysis and PD mostly, but the companies didn’t even bother coming to 🇨🇦) (Disclosure we wrote this: evidence.nejm.org/doi/abs/10.1... mostly Jeff Ha and @sunilbadve.bsky.so…

Are you using HIF-PHIs? (I would love to try in predialysis and PD mostly, but the companies didn’t even bother coming to 🇨🇦) (Disclosure we wrote this: evidence.nejm.org/doi/abs/10.1... mostly Jeff Ha and @sunilbadve.bsky.social )

I know you've co-authored a paper on HIF-PHI. What are the drugs available in Canada in this regard and do you use them in the non dialysis population as well? evidence.nejm.org/doi/full/10....

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.